Verition Fund Management LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$8,233,000
-3.1%
8,091,0000.0%0.10%
+62.3%
Q4 2021$8,496,000
+0.2%
8,091,0000.0%0.06%
-16.4%
Q3 2021$8,475,000
-2.8%
8,091,0000.0%0.07%
-7.6%
Q2 2021$8,718,000
-6.3%
8,091,0000.0%0.08%
-24.8%
Q1 2021$9,305,000
-11.5%
8,091,0000.0%0.10%
+14.1%
Q4 2020$10,509,000
+14.6%
8,091,0000.0%0.09%
-49.7%
Q3 2020$9,169,000
+37.5%
8,091,000
+40.8%
0.18%
-16.4%
Q2 2020$6,670,000
+115.4%
5,748,000
+108.1%
0.22%
+79.5%
Q1 2020$3,096,000
-3.2%
2,762,0000.0%0.12%
+110.3%
Q4 2019$3,197,000
+117.2%
2,762,000
+95.2%
0.06%
+41.5%
Q3 2019$1,472,0001,415,0000.04%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$31,610,0000.98%
Opti Capital Management, LP 8,000,000$8,206,0000.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,076,0000.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$15,848,0000.31%
CSS LLC/IL 7,007,000$7,112,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 17,479,000$17,762,0000.17%
LMR Partners LLP 9,500,000$9,933,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 4,672,000$4,858,0000.11%
Verition Fund Management LLC 8,091,000$8,233,0000.10%
Aequim Alternative Investments LP 2,000,000$2,035,0000.05%
View complete list of PTC THERAPEUTICS INC shareholders